Irving Sucholeiki

Irving Sucholeiki

Company: Aquilus Pharmaceuticals

Job title: President & Chief Executive Officer


Development of a Matrix Metalloproteinase-2/-9 Inhibitor for the Treatment of Neuropathic Pain 12:30 pm

Using “operant” pain read-outs in animal models to better predict clinical efficacy Introducing “real world” pain conditions in rodent models that better translate to human pain conditions Using biomarkers to better gauge target engagement and relevance to human diseaseRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.